The STD market growth is strongly driven by high incidence rates and increase in prevalence rates of STDs such as chlamydia, syphilis, and gonorrhea. Moreover, implementation of national screening programs to improve and increase the STD diagnosis in many key geographies such as U.S., UK, Canada, and support in reimbursement for STDs testing are further …